Trials / Conditions / HIV-Associated Lipodystrophy Syndrome

HIV-Associated Lipodystrophy Syndrome

15 registered clinical trials studyying HIV-Associated Lipodystrophy Syndrome.

Status	Trial	Sponsor	Phase
Completed	Contribution of Dolutegravir to Obesity and Cardiovascular Disease NCT04340388	Augusta University	Phase 4
Completed	An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Sing NCT01848340	ViiV Healthcare	Phase 1
Unknown	Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone NCT00662181	Hvidovre University Hospital	—
Completed	Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatro NCT00383734	French National Agency for Research on AIDS and Viral Hepatitis	Phase 3
Completed	Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome NCT01359917	NHS Lothian	—
Completed	Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome NCT00135356	Bristol-Myers Squibb	Phase 4
Completed	Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance NCT00130286	Weill Medical College of Cornell University	Phase 1 / Phase 2
Completed	Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/A NCT00139178	Danish HIV Research Group	Phase 4
Terminated	Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients NCT00122668	French National Agency for Research on AIDS and Viral Hepatitis	Phase 4
Completed	A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth NCT00069004	National Institute of Allergy and Infectious Diseases (NIAID)	—
Unknown	Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patie NCT00135460	Danish HIV Research Group	Phase 4
Completed	HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001) NCT00192660	Kirby Institute	Phase 4
Terminated	Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 1 NCT00148850	French National Agency for Research on AIDS and Viral Hepatitis	Phase 3
Unknown	MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS) NCT00122226	Amsterdam UMC, location VUmc	Phase 4
Completed	Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy NCT00646984	Hospital Clinic of Barcelona	Phase 4